STOCK TITAN
  1. Home
  2. Sec-filings
  3. GLUE
  4. [144] Monte Rosa Therapeutics, Inc. SEC Filing

GLUE (NASDAQ: GLUE) holder to sell 9,500 shares under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

GLUE shareholder Markus Warmuth filed a notice to sell up to 9,500 shares of GLUE common stock under Rule 144 through Morgan Stanley Smith Barney LLC, with an aggregate market value of $220,218.55. The approximate sale date is July 16, 2026 on NASDAQ.

The 9,500 shares derive from restricted stock acquired from the issuer, including 8,678 shares granted on September 1, 2021 and 822 shares on December 1, 2021. In the past three months, Warmuth sold 5,466 shares for $106,253.04 on June 1, 2026 and 5,467 shares for $103,446.57 on May 1, 2026. Shares outstanding were 84,479,418.

Positive

  • None.

Negative

  • None.
Shares to be sold 9,500 shares Planned Rule 144 sale of GLUE common stock
Aggregate market value $220,218.55 Total market value of 9,500 GLUE shares to be sold
Shares outstanding 84,479,418 shares GLUE common stock outstanding referenced in the notice
Restricted stock grant 8,678 shares Restricted GLUE shares acquired on September 1, 2021
Restricted stock grant 822 shares Restricted GLUE shares acquired on December 1, 2021
Recent sale 5,466 shares for $106,253.04 GLUE common stock sold on June 1, 2026
Recent sale 5,467 shares for $103,446.57 GLUE common stock sold on May 1, 2026
Form 144 regulatory
"144: Filer Information | | | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Restricted Stock financial
"Common | 09/01/2021 | Restricted Stock | Issuer"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Aggregate market value financial
"Common | Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004 | 9500 | 220218.55"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What does the Form 144 for GLUE disclose about planned share sales?
The Form 144 discloses a planned sale of up to 9,500 GLUE common shares under Rule 144, with an aggregate market value of $220,218.55. The approximate sale date is July 16, 2026 on NASDAQ through Morgan Stanley Smith Barney LLC.

Who is the GLUE shareholder filing the Form 144 and what is being sold?
The shareholder is Markus Warmuth, who filed to sell up to 9,500 shares of GLUE common stock. These shares come from restricted stock acquired from the issuer in 2021, in two grants of 8,678 and 822 shares respectively.

What prior GLUE share sales are reported in the last three months?
The notice reports two prior GLUE common stock sales: 5,466 shares sold on June 1, 2026 for $106,253.04 and 5,467 shares sold on May 1, 2026 for $103,446.57. These transactions occurred within the three months preceding the planned Rule 144 sale.

What is the size of GLUE’s outstanding shares referenced in the Form 144?
The notice states that there are 84,479,418 shares of GLUE common stock outstanding. This figure provides context for the planned Rule 144 sale of 9,500 shares, indicating the overall share base relative to the proposed disposition.

How and where will the GLUE shares under Form 144 be sold?
The GLUE shares are expected to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with an approximate sale date of July 16, 2026. The common stock is listed on NASDAQ, and the aggregate market value of the planned sale is $220,218.55.

When were the GLUE restricted shares planned for sale originally acquired?
The restricted GLUE shares planned for sale were acquired from the issuer on September 1, 2021 and December 1, 2021. The respective grants were for 8,678 and 822 common shares, which together make up the 9,500 shares covered by this Rule 144 notice.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR